Seeing Is Believing
Healthcare - Sector
BEAM is currently covered by 11 analysts with an average price target of $49.39. This is a potential upside of $24.23 (96.3%) from yesterday's end of day stock price of $25.16.
Beam Therapeutics 's activity chart (see below) currently has 127 price targets and 94 ratings on display. The stock rating distribution of BEAM is 75% BUY and 25% HOLD.
Analysts average stock forecasts to be materialized ratio is 40.02% with an average time for these price targets to be met of 88 days.
Highest price target for BEAM is $80, Lowest price target is $21, average price target is $47.44.
Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH on 25-Feb-2026. First documented stock forecast 02-Mar-2020.
Currently out of the existing stock ratings of BEAM, 12 are a BUY (75%), 4 are a HOLD (25%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Mar-2020
$65
$38.46 (144.91%)
$57
16 days ago
(25-Feb-2026)
3/8 (37.5%)
$35.84 (122.91%)
154
Hold Since 03-May-2021
$26
$-0.54 (-2.03%)
$20
16 days ago
(25-Feb-2026)
9/10 (90%)
$-3.16 (-10.84%)
52
Hold Since 08-Dec-2023
$28
$1.46 (5.50%)
$30
2 months 6 days ago
(07-Jan-2026)
4/4 (100%)
$-0.93 (-3.21%)
133
Buy Since 23-Jul-2024
$80
$53.46 (201.43%)
$80
5 months 3 days ago
(10-Oct-2025)
0/9 (0%)
$53.68 (203.95%)
Buy Since 12-Mar-2025
6 months 22 days ago
(19-Aug-2025)
1/10 (10%)
$12.38 (46.51%)
118
What is BEAM (Beam Therapeutics ) average time for price targets to be met?
Which analyst has the current highest performing score on BEAM (Beam Therapeutics ) with a proven track record?
Which analyst has the most public recommendations on BEAM (Beam Therapeutics )?
Which analyst is the currently most bullish on BEAM (Beam Therapeutics )?
Which analyst is the currently most reserved on BEAM (Beam Therapeutics )?